October 31, 2018

Seattle Children’s launches trial aimed at solid cancer tumors

Seattle Children’s is working on immunotherapy for solid tumors like 8-year-old Mason's so that he and other kids can avoid harmful medicines and procedures. The STRIvE-01 trial is currently recruiting children with solid tumor cancers that either couldn’t be cured or reoccurred.
October 24, 2018

One family’s incredible journey to wellness

At age 3 months, Greta was diagnosed with a rare form of leukemia and needed a bone marrow transplant, which was successful but led to complications. Three months later, Greta relapsed, and her parents, who live in Portland, found a Stand Up To Cancer – St. Baldrick’s Pediatric Cancer Dream Team clinical trial at Seattle Children’s that was accepting babies.
October 17, 2018

Seattle fundraiser benefits pediatric cancer research

Be Bold, Be Bald! is an annual event that raises money and awareness for the fight against cancer. Money from this year's Be Bold, Be Bald! will benefit Crush Kids' Cancer (CKC), a fundraising guild for Seattle Children's.
October 15, 2018

Leaders in medicine meet in London to discuss T cell immunotherapy

At 2, Erin Cross was diagnosed with acute lymphoblastic leukemia and her one chance at a miracle came in the form of a cancer treatment trial at Seattle Children’s Hospital: a new form of T cell immunotherapy — one that if successful, held the promise of saving countless other young lives.